EE Impact

Acino International AG

Switzerland · Pharma & Healthcare

LeaveRussia detail: Withdrawal

Exited Russia

Swiss based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery

Status last verified 03/08/2026Source checked 11/12/2023Company website ↗LeaveRussia profile ↗

Business in Russia

10.2023: The record about the founders of ASINO INTERNATIONAL AG and ASINO PHARMA AG was removed from EGRUL. SALUS RESTRICTED LTD and SALUS 2 RESTRICTED LTD become the new founders of the organization.

Decision trail

Decision date 30/11/2023 · Reference ↗

Acino's parent company, headquartered in Zurich, Switzerland, sold an asset in the Russian Federation in 2023 and no longer does business in that country. But Acino doesn't appear to have totally left Russia, they seem to have transferred the shares to a related companies in the UAE. The parent company of ACINO is ADQ based in UAE. Acino in Switzerland has made no official announcement that they left Russia.

Local stats (LeaveRussia)

Assets(RF), mln.USD
30
Capital(RF), mln.USD
8
Revenue(RF), mln.USD
42
Staff(RF), 2021
108
Taxes(RF), mln.USD
1

Status history since 2022

  1. 03/08/2026 exited · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.